Ewaisha R - Search Results

1

Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.

Ferdosi SR, Ewaisha R, Moghadam F, Krishna S, Park JG, Ebrahimkhani MR, Kiani S, Anderson KS. Ferdosi SR, et al. Among authors: ewaisha r. Nat Commun. 2019 Apr 23;10(1):1842. doi: 10.1038/s41467-019-09693-x. Nat Commun. 2019. PMID: 31015529 Free PMC article.

2

Proteomic Monitoring of B Cell Immunity.

Ewaisha R, Anderson KS. Ewaisha R, et al. Methods Mol Biol. 2016;1403:131-52. doi: 10.1007/978-1-4939-3387-7_6. Methods Mol Biol. 2016. PMID: 27076128 Free PMC article.

3

Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.

Ewaisha R, Gawryletz CD, Anderson KS. Ewaisha R, et al. Expert Rev Proteomics. 2016;13(2):201-11. doi: 10.1586/14789450.2016.1132170. Epub 2016 Jan 4. Expert Rev Proteomics. 2016. PMID: 26653344 Review.

4

Programmable protein arrays for immunoprofiling HPV-associated cancers.

Ewaisha R, Meshay I, Resnik J, Katchman BA, Anderson KS. Ewaisha R, et al. Proteomics. 2016 Apr;16(8):1215-24. doi: 10.1002/pmic.201500376. Epub 2016 Apr 4. Proteomics. 2016. PMID: 27089055 Free PMC article.

5

Serum Immune Profiling for Early Detection of Cervical Disease.

Ewaisha R, Panicker G, Maranian P, Unger ER, Anderson KS. Ewaisha R, et al. Theranostics. 2017 Aug 23;7(16):3814-3823. doi: 10.7150/thno.21098. eCollection 2017. Theranostics. 2017. PMID: 29109779 Free PMC article.

6

Performance Characteristics of a Calculated Index Control Method for the phi Multianalyte Assay with Algorithmic Analysis.

Ewaisha R, Flieth TL, Ness KM, Algeciras-Schimnich A, Bornhorst JA. Ewaisha R, et al. J Appl Lab Med. 2024 Nov 8:jfae110. doi: 10.1093/jalm/jfae110. Online ahead of print. J Appl Lab Med. 2024. PMID: 39511905

7

Immunogenicity of CRISPR therapeutics-Critical considerations for clinical translation.

Ewaisha R, Anderson KS. Ewaisha R, et al. Front Bioeng Biotechnol. 2023 Feb 16;11:1138596. doi: 10.3389/fbioe.2023.1138596. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 36873375 Free PMC article. Review.

8

Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds.

Larkey NE, Ewaisha R, Lasho MA, Roforth MM, Granger D, Jerde CR, Wu L, Gorsh A, Klassen SA, Senefeld JW, Joyner MJ, Baumann NA, Theel ES, Mills JR. Larkey NE, et al. Among authors: ewaisha r. Microbiol Spectr. 2022 Aug 31;10(4):e0115422. doi: 10.1128/spectrum.01154-22. Epub 2022 Jul 5. Microbiol Spectr. 2022. PMID: 35862939 Free PMC article.

9

Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.

Mossallam SF, Amer EI, Ewaisha RE, Khalil AM, Aboushleib HM, Bahey-El-Din M. Mossallam SF, et al. Among authors: ewaisha re. BMC Infect Dis. 2015 Mar 24;15:147. doi: 10.1186/s12879-015-0906-z. BMC Infect Dis. 2015. PMID: 25887456 Free PMC article.

10

Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.

Ewaisha RE, Bahey-El-Din M, Mossallam SF, Amer EI, Aboushleib HM, Khalil AM. Ewaisha RE, et al. Exp Parasitol. 2014 Oct;145:51-60. doi: 10.1016/j.exppara.2014.07.010. Epub 2014 Aug 1. Exp Parasitol. 2014. PMID: 25092439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters